Moreover, CD25 is also shown to be expressed in the leukemic stem cell compartment of CML, suggesting an additional potential beneficial effect of this approach for the eradication of CML stem cells. The gene discussed is IL2RA; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.